Skip to main content
. 2020 Nov 28;214:105782. doi: 10.1016/j.actatropica.2020.105782

Fig. 1.

Figure 1

Impact of active and prior dengue fever on COVID-19 symptomatology. A) Symptom frequency in COVID-19 versus COVID-19/dengue fever co-infection (SARS-CoV-2 +/ anti-dengue virus IgM +) patients. B) Symptom frequency in COVID-19 (SARS-CoV-2 +/ anti-dengue virus IgG -) versus COVID-19/past dengue fever (SARS-CoV-2 +/ anti-dengue virus IgG +) patients. *p<0.05.